Cancer Biology Program - UT Houston, GSBS

at , Houston, 77030 United States

Cancer Biology Program at UT Houston, Graduate School of Biomedical Sciences


Cancer Biology Program - UT Houston, GSBS

Houston , TX 77030
United States

Company Rating

1 Facebook users were in Cancer Biology Program - UT Houston, GSBS. It's a 91 position in Popularity Rating for companies in Education category in Houston, Texas

56 FB users likes Cancer Biology Program - UT Houston, GSBS, set it to 109 position in Likes Rating for Houston, Texas in Education category

Generated summary (experimental)

The Cancer Biology Program at The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS) in Houston is dedicated to providing students with the highest quality of training in diverse areas of cancer biology research.
Given the unique environment of the Texas Medical Center, the philosophy of the Cancer Biology Program is to supplement traditional graduate school training with both depth and breadth of knowledge in cancer biology.
The program faculty are eager to train motivated students, and will gladly provide additional information with respect to their research programs and training opportunities in their laboratories.
A systematic training in cancer biology should allow our students to meet the challenge of Making Cancer History.
Students affiliated with legacy programs (i.e., those that existed before the GSBS program reorganization), may click here to find information about their program requirements.
Selected by the Student Scholarship Committee and the GSBS Deans as one of the recipients of the 2019-2020 Scholarship for Excellence in Biochemistry and Molecular Biology at MD Anderson Cancer Center.
Selected by the Student Scholarship Committee and the GSBS Deans as one of the recipients of the 2019-2020 Scholarship for Excellence in Biochemistry and Molecular Biology at MD Anderson Cancer Center.
Selected by the Student Scholarship Committee and the GSBS Deans as one of the recipients of this year's American Legion Auxiliary Fellowship in Cancer Research.
Selected by the Student Scholarship Committee and the GSBS Deans as the recipient of the 2019-2020 Larry Deaven Ph.D. Fellowship in Biomedical Sciences.
(2) Selected as one of the recipients of the 2018-2019 Sylvan Rodriguez Foundation Scholarship honoring George M. Stancel, Ph.D. which is awarded to GSBS pre-candidacy students who demonstrate the potential to be both outstanding cancer researchers and contributors to public awareness about cancer research.
This $5,000 Scholarship is awarded to a GSBS doctoral candidate who is doing promising cancer research and has also made significant contributions to community service and/or the promotion of science education.
(1) Recipient of 2017-2018 Sylvan Rodriguez Foundation Scholarship honoring George M. Stancel, Ph.D. (2) Selected by the GSBS Student Scholarship Committee and the GSBS Deans as the recipient of the 2018-2019 Ellen Taylor Goldin Legacy Scholarship.
(2) Selected by the GSBS Student Scholarship Committee and the GSBS Deans as the recipient of the 2018-2019 Jesse B. Heath, Jr. Family Legacy Award.
Selected by the Student Scholarship Committee and the GSBS Deans as one of the recipients of the 2018-2019 Andrew Sowell-Wade Huggins Scholarship in Cancer Research.
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.
Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy.
Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis.
Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers.